Mark Woodward's Publications

About Mark Woodward's Publications

Senior Professorial Fellow, Professorial Unit
  • Chair of Statistics, Epidemiology and Women’s Health at Imperial College London
  • Professor of Medical Statistics, Faculty of Medicine, UNSW Sydney
  • PhD ,
  • FMedSci,
  • FAHMS,
  • FESC

  • Effect of randomised blood pressure lowering treatment and intensive glucose control on dementia and cognitive decline according to baseline cognitive function and other subpopulations of individuals with type 2 diabetes: Results from the ADVANCE trial

    Cerebral Circulation - Cognition and Behavior Date published:

  • Mixture analysis of associations between environmental and workplace toxins and liver damage and telomere length, stratified by race/ethnicity

    Journal of Environmental Sciences Date published:

  • Heavy metals are liver fibrosis risk factors in people without traditional liver disease etiologies

    Journal of Environmental Sciences Date published:

  • Health and economic benefits of improving pre-hospital identification of stroke in Australian women: a modelling study

    Medical Journal of Australia Date published:

  • The relationships between MASLD, extrahepatic multimorbidity and all-cause mortality in UK Biobank cohort

    The Journal of Clinical Endocrinology & Metabolism Date published:

  • Performance of the revised World Health Organization cardiovascular disease risk prediction models for the Middle East and North Africa: a validation study in the Tehran Lipid and Glucose Study

    Journal of Clinical Epidemiology Date published:

  • Role of Sex Hormones in Mediating Adiposity Changes From Weight Loss in People With Type 2 Diabetes: Look AHEAD Sex Hormone Study

    The Journal of Clinical Endocrinology & Metabolism Date published:

  • Frailty and prescriptions of secondary prevention medications in older people with diabetes and coronary heart disease-An observational study in Vietnam

    Australasian Journal on Ageing Date published:

  • Relationship between time-varying achieved HbA1cand risk of coronary artery disease events among common haptoglobin phenotype groups with type 2 diabetes: the ADVANCE study

    BMJ Open Diabetes Research & Care Date published:

  • Blood Pressure Lowering and Risk of Cancer

    JACC: CardioOncology Date published:

  • Cardiovascular disease outcomes in relation to 25-hydroxyvitamin D and its seasonal variation: Results from the BiomarCaRE consortium

    PLOS One Date published:

  • The Clinical Implications of Slope of Glomerular Filtration Rate in Clinical Trials of Chronic Kidney Disease

    Clinical Journal of the American Society of Nephrology Date published:

  • A health economic evaluation of the multinational, randomized controlled CONVINCE trial: cost-utility of high-dose online hemodiafiltration compared to high-flux hemodialysis

    Kidney International Date published:

  • Assessing patterns of chronic kidney disease care in Australian primary care: a retrospective cohort study of a national general practice dataset

    The Lancet Regional Health - Western Pacific Date published:

  • Diet Quality Indices, All-Cause Mortality, Cardiovascular Disease, and Dementia-Outcomes from the Australian Longitudinal Study on Women’s Health

    The Journal of Nutrition Date published:

  • STatin TReatment for COVID-19 to Optimise NeuroloGical recovERy (STRONGER): study protocol for a randomised, open label clinical trial in patients with persistent neurological symptoms after COVID-19 infection

    BMJ Open Date published: